Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam and postoperative delirium in elderly joint replacement patients
ChiCTR2300072421Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative delirium (POD) comparing Midazolam induction with Normal saline induction (placebo) (2 arms). Primary endpoint: Incidence of postoperative delirium. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
midazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2300072421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072421.